• Topics

  • Formats

Tom Lampron, VP Global Commercial Pancreas Lead at Revolution Medicines, explores what it really takes to launch a new medicine or indication in today's complex healthcare environment.

Drawing on experience from more than 30 launches, Tom discusses how pharma teams can drive behaviour change across clinicians, payers, systems and patients — and why the first six months can define long-term success.

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?